AstraZeneca PLC (AZN) Announces Approval of Saphnelo by the European Union

​AstraZeneca PLC (NASDAQ:AZN) is one of the Best Non-US Stocks to Buy According to Hedge Funds. On December 16, AstraZeneca PLC (NASDAQ:AZN) announced the approval of its Saphnelo by the European Union for subcutaneous self-administration to treat adults with systemic lupus erythematosus along with the standard therapy. ​Management noted that the approval is based on the positive results from the Phase III TULIP-SC trial and follows a positive opinion from the Committee for Medicinal Products for Human U ...